Luteolin enhances drug chemosensitivity by downregulating the FAK/PI3K/AKT pathway in paclitaxel‑resistant esophageal squamous cell carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Luteolin enhances drug chemosensitivity by downregulating the FAK/PI3K/AKT pathway in paclitaxel‑resistant esophageal squamous cell carcinoma

Published:2024-07-10 Issue:3 Volume:54 Page:
ISSN:1107-3756
Container-title:International Journal of Molecular Medicine
language:
Short-container-title:Int J Mol Med

Author:

Yang Zhenzhen¹,Liu Hongtao²,Song Yinsen¹,Gao Na¹,Gao Pan¹,Hui Yiran³,Li Yueheng³,Fan Tianli³

Affiliation:

1. The Fifth Clinical Medical College of Henan University of Chinese Medicine (Zhengzhou People's Hospital), Zhengzhou, Henan 450003, P.R. China

2. School of Life Sciences, Zhengzhou University, Zhengzhou, Henan 450001, P.R. China

3. School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, Henan 450001, P.R. China

Publisher

Spandidos Publications

Reference24 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. Epidemiology of esophageal cancer;Zhang;World J Gastroenterol,2013

3. Epidemiology of esophageal squamous cell carcinoma;Abnet;Gastroenterology,2018

4. Cancer statistics, 2013;Siegel;CA Cancer J Clin,2013

5. Epidemiology of esophageal cancer in Japan and China;Lin;J Epidemiol,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP